Enzymes that are drug targets for NCDs include lipase (obesity), α-amylase and α-glucosidase (diabetes), angiotensin-converting enzyme (ACE) (hypertension) as well as acetylcholinesterase (AChE), butyrylcholinesterase (BChE) and β-secretase (BACE-1) (AD). This evidence concerns the gene BCHE and diabetes mellitus.